While lawmakers debate how to correct the unintended consequences of the America Invents Act, more drug- and device-makers risk being held up by reverse patent trolls threatening to challenge their ...
A big story last year was the emergence of hedge funds and other entities using the Patent Trial and Appeal Board. While Kyle Bass is seeing his IPRs through to final decision, other entities are ...
The authors of a new white paper believe that almost 75% of pharmaceutical patent settlements at the Patent Trial and Appeal Board meet the criterion for inferring a strong likelihood of reverse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback